Taghi Manshouri
- Genetics top 0.1%
- Hematology top 0.2%
- Molecular Biology top 2%
- Oncology top 2%
- Rheumatology top 0.5%
- Co-authors
- Hagop M. KantarjianSrđan VerstovšekMaher AlbitarJörge E. CortesMichael J. KeatingZeev EstrovDeborah A. ThomasFrancis J. Giles
- Topics
- Myeloproliferative Neoplasms: Diagnosis and Treatment (64 papers)Chronic Myeloid Leukemia Treatments (48 papers)Acute Myeloid Leukemia Research (38 papers)
- Cited by
- GeneticsHematologyRheumatology
- Partner nations
- United StatesCroatiaSwitzerland
In The Last Decade
Taghi Manshouri
135 papers receiving 6.1k citations
Hit Papers
Peers
Comparison fields: 5 of 102
- Genetics 3.2k
- Hematology 3.1k
- Molecular Biology 3.0k
- Oncology 1.3k
- Rheumatology 1.2k
Countries citing papers authored by Taghi Manshouri
This map shows the geographic impact of Taghi Manshouri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Taghi Manshouri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Taghi Manshouri more than expected).
Fields of papers citing papers by Taghi Manshouri
This network shows the impact of papers produced by Taghi Manshouri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Taghi Manshouri. The network helps show where Taghi Manshouri may publish in the future.
Co-authorship network of co-authors of Taghi Manshouri
This figure shows the co-authorship network connecting the top 25 collaborators of Taghi Manshouri. A scholar is included among the top collaborators of Taghi Manshouri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Taghi Manshouri. Taghi Manshouri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 1 | |
| 5 | 1 | |
| 6 | 115 | |
| 7 | 29 | |
| 8 | 83 | |
| 9 | 83 | |
| 10 | 80 | |
| 11 | 227 | |
| 12 | 13 | |
| 13 | 66 | |
| 14 | The dual ABL/SRC inhibitors dasatinib, SKI-606, and INNO-406 are potent inhibitors of T cell acute lymphoblastic leukemia cell lines expressing the NUP214-ABL1 fusion kinase | 1 |
| 15 | 16 | |
| 16 | 11 | |
| 17 | 11 | |
| 18 | Significance of FHIT expression in chronic myelogenous leukemia. | 9 |
| 19 | 15 | |
| 20 | 27 |
About Taghi Manshouri
Taghi Manshouri is a scholar working on Genetics, Hematology and Rheumatology, having authored 143 papers that have together received 6.2k indexed citations. Recurring topics across this work include Myeloproliferative Neoplasms: Diagnosis and Treatment (64 papers), Chronic Myeloid Leukemia Treatments (48 papers) and Acute Myeloid Leukemia Research (38 papers). The work is most often cited by research in Genetics (3.2k citations), Hematology (3.1k citations) and Rheumatology (1.2k citations). Taghi Manshouri has collaborated with scholars based in United States, Croatia and Switzerland. Frequent co-authors include Hagop M. Kantarjian, Srđan Verstovšek, Maher Albitar, Jörge E. Cortes, Michael J. Keating, Zeev Estrov, Deborah A. Thomas, Francis J. Giles, Susan O’Brien and Alfonso Quintás‐Cardama. Their work appears in journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.